Daily Judi: Monday, March 13, 2023
Every day we scan the headlines for the best items that engage the clinical trial ecosystem, workflow solutions, and more—all the latest news you need to know. Here are today's stories:
NPR looks at diversity in Alzheimer's clinical trials, and the breakthrough treatment, lecanemab.
Meanwhile Keristen Holmes examines FDA initiatives to attract diverse participants to clinical trials. (CBS News 8)
Ashley Capoot reports that Science, a company within the brain-computer interface industry, and competitor with Neuralink, has launched a platform called Science Foundry, enabling medical device makers to access its tools. Science Co-Founder and CEO Max Hodak said, “Hopefully, we bring down the barriers to innovation.” (CNBC)
Our Culture
“The final product that the client receives is fully configured to their trial, their forms, their workflow.”
–Jess, Program Manager
About Judi
Judi speeds and improves the world's clinical trial workflows. Our cloud-based platform has 120,000 users across 171 countries. We eliminate the chaos so clinical teams can focus on the patient, rather than the process. We are a SOC 2 certified collaboration platform.
